Lorsque le patient obèse ne perd pas de poids ou continue a en prendre... [When the obese patient can't lose any weight or keeps putting some on].

The traditional obesity treatments have proven to be ineffective in the long-term. The presence of eating disorders frequently explains this phenomena. Eating educational and behavioral aspects must be addressed in a practical way so that patients could gradually become aware of their behavior towards food as well as internal sensations associated with hunger, satiety, craving and pleasure. Finally, the link between emotions and compulsive eating behaviors during and between meals is an essential aspect that the general practitioner can help the patient to understand. A specialized psychological treatment can then be considered when the patient shows sufficient motivation and consciousness.

Expanding view of phenotype and oxidative stress in Friedreich's ataxia patients with and without idebenone

Summary: Friedreich's ataxia (FRDA), the most common autosomal recessive ataxia, is characterised by progressive ataxia with dysarthria of speech, loss of deep-tendon reflexes, impaired vibratory and proprioceptive sensations and corticospinal weakness with a Babinski's sign. Patients eventually also develop kyphoscoliosis, cardiomyopathy and diabetes mellitus. The disease is a GAA repeat disorder resulting in severely reduced levels of frataxin, with secondary increased sensitivity to oxidative stress. The anti-oxidative drug, idebenone, is effective against FRDA-associated cardiomyopathy. We provide detailed clinical, electrophysiological and biochemical data from 20 genetically confirmed FRDA patients and have analysed the relation-ship between phenotype, genotype and malondialdehyde (MDA), which is a marker of superoxide formation. We assessed the effects of idebenone biochemically by measuring blood M DA and clinically by serial measurements of the International Cooperative Ataxia Rating Scale (ICARS). The GAA repeat length influenced the age at onset (p <0.001), the severity of ataxia (p= 0.02), the presence of cardiomyopathy (p =0.04) and of low-frequency hearing loss (p = 0.009). Multilinear regression analysis showed (p = 0.006) that ICARS was dependent on the two variables of disease duration (p = 0.01) and size of the GAA expansion (p = 0.02). We found no correlation to bilateral palpebral ptosis visual impairment, diabetes mellitus or skeletal deformities, all of which appear to be signs of disease progression rather than severity. We discuss more thoroughly two underrecognised clinical findings: palpebral ptosis and GAA length-dependent low-frequency hearing loss. The average ICARS remained unchanged in 10 patients for whom follow-up on treatment was available (mean 2.9 years), whereas most patients treated with idebenone reported an improvement in dysarthria (63%), hand dexterity (.58%) and fatigue (47%) after taking the drug for several weeks or months. Oxidative stress analysis showed an unexpected increase in blood MDA levels in patients on idebenone (p = 0.04), and we discuss the putative underlying mechanism for this result, which could then explain the unique efficacy of idebenone in treating the FRDA-associated cardiomyopathy, as opposed to other antioxidative drugs. Indeed, idebenone is not only a powerful stimulator of complexes II and III of the respiratory chain, but also an inhibitor of complex I activity, then promoting superoxide formation. Our preliminary clinical observations are the first to date supporting an effect of idebenone in delaying neurological worsening. Our MDA results point to the dual effect of idebenone on oxidative stress and to the need for controlled studies to assess its potential toxicity at high doses on the one hand, and to revisit the exact mechanisms underlying the .physiopathology of Friedreich's ataxia on the other hand, while recent reports suggest non-oxidative pathophysiology of the disease.

Etude des Liens entre Activité Physique et Traits de la Personnalité

Le mode de vie toujours plus sédentaire des individus dans notre société pousse les professionnels de la santé à chercher de nouvelles stratégies en matière de promotion de l'activité physique. Cette étude, réalisée à l'aide de la distribution d'un questionnaire dans une population âgée entre 25 et 50 ans, vise à mesurer les liens entre l'attirance envers l'activité physique, les caractéristiques individuelles (lieu d'habitation, âge, genre, etc.) et les traits de personnalité (anxiété, névrosisme, extraversion, etc.). L'attirance envers l'activité sportive est évaluée sous forme d'attributs liés au sport, tels que « équipe », « endurance », « loisirs », « sthétisme », etc. Les résultats montrent que 1) le névrotisme et le psychoticisme ne sont positivement liés à aucun de ces attributs. Conformément à la littérature, l'extraversion, la susceptibilité à l'ennui et la recherche de sensations sont liés au plus grand nombre d'attributs; 2) l'estime de soi et les croyances sur la santé favorisant l'anxiété sont deux traits nouveaux issus de nos résultats. En effet, l'estime de soi est liée aux attributs « loisirs » et « santé », et les croyances sur la santé sont liées aux attributs « individuel », « esthétisme », « prestige » et « santé »; 3) le BMI, l'âge et le genre sont également des facteurs discriminants concernant les raisons de pratiquer une activité sportive. En conclusion, bien que des recherches complémentaires soient nécessaires, le succès de l'adhésion à une pratique régulière et à long terme dépend d'un conseil adapté à chaque individu selon ses caractéristiques individuelles et ses traits de personnalité.